IMMUNOVIA AB news, videos and press releases - Page 2
For more news please use our advanced search feature.
IMMUNOVIA AB - More news...
IMMUNOVIA AB - More news...
- Change in number of shares and votes in Immunovia AB (publ)
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
- Immunovia Publishes Interim Report for January-June 2024
- Immunovia Publishes Interim Report for January-June 2024
- Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health
- Immunovia files US patent application to protect its next-generation test
- Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy
- Invitation to Immunovia's Q2 presentation
- Invitation to Immunovia's Q2 presentation
- Immunovia's new lab staffed and operational after rapid implementation
- BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)
- BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)
- NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)
- NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)
- Immunovia carries out a rights issue of units of approximately SEK 70 million and raises bridge loans
- Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina
- Immunovia appoints Dr. Lisa Ford as Clinical Laboratory Director
- Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina
- Immunovia publishes the annual report for 2023
- Immunovia publishes the annual report for 2023
- Immunovia Publishes Interim Report for January-March 2024
- Immunovia Publishes Interim Report for January-March 2024
- Invitation to Immunovia's Q1 presentation
- Invitation to Immunovia's Q1 presentation
- Immunovia announces updated financial calendar
- Immunovia announces updated financial calendar
- Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
- Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study
- Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study
- Immunovia announces updated financial calendar
